Cosmo Bio Company,Limited (3386.T)

JPY 1154.0

(0.17%)

Total Debt Summary of Cosmo Bio Company,Limited

  • Cosmo Bio Company,Limited's latest annual total debt in 2023 was 20 Million JPY , down 0.0% from previous year.
  • Cosmo Bio Company,Limited's latest quarterly total debt in 2024 Q2 was 418 Million JPY , down 0.0% from previous quarter.
  • Cosmo Bio Company,Limited reported annual total debt of 20 Million JPY in 2022, down 0.0% from previous year.
  • Cosmo Bio Company,Limited reported annual total debt of 20 Million JPY in 2021, down 0.0% from previous year.
  • Cosmo Bio Company,Limited reported quarterly total debt of 418 Million JPY for 2024 Q2, down 0.0% from previous quarter.
  • Cosmo Bio Company,Limited reported quarterly total debt of 20 Million JPY for 2023 Q3, down 0.0% from previous quarter.

Annual Total Debt Chart of Cosmo Bio Company,Limited (2023 - 2019)

Historical Annual Total Debt of Cosmo Bio Company,Limited (2023 - 2019)

Year Total Debt Total Debt Growth
2023 20 Million JPY 0.0%
2022 20 Million JPY 0.0%
2021 20 Million JPY 0.0%
2020 20 Million JPY 0.0%
2019 20 Million JPY 0.0%

Peer Total Debt Comparison of Cosmo Bio Company,Limited

Name Total Debt Total Debt Difference
Shin Nippon Biomedical Laboratories, Ltd. 26.33 Billion JPY 99.924%
DNA Chip Research Inc. - JPY -Infinity%
H.U. Group Holdings, Inc. 81.94 Billion JPY 99.976%
FALCO HOLDINGS Co., Ltd. 817 Million JPY 97.552%
BML, Inc. 5.26 Billion JPY 99.62%
Human Metabolome Technologies, Inc. 226.3 Million JPY 91.162%
Precision System Science Co., Ltd. 1.36 Billion JPY 98.537%